Organon Q1 2024 Adj EPS $1.22 Beats $0.93 Estimate, Sales $1.622B Beat $1.563B Estimate
Organon Q1 2024 Adj EPS $1.22 Beats $0.93 Estimate, Sales $1.622B Beat $1.563B Estimate
Organon 2024年第一季度调整后每股收益1.22美元超过0.93美元的预期，16.22亿美元的销售额超过15.63亿美元的预期
Organon (NYSE:OGN) reported quarterly earnings of $1.22 per share which beat the analyst consensus estimate of $0.93 by 31.18 percent. This is a 12.96 percent increase over earnings of $1.08 per share from the same period last year. The company reported quarterly sales of $1.622 billion which beat the analyst consensus estimate of $1.563 billion by 3.76 percent. This is a 5.46 percent increase over sales of $1.538 billion the same period last year.
Organon（纽约证券交易所代码：OGN）公布的季度收益为每股1.22美元，比分析师普遍预期的0.93美元高出31.18％。这比去年同期的每股收益1.08美元增长了12.96％。该公司公布的季度销售额为16.22亿美元，比分析师普遍预期的15.63亿美元高出3.76％。这比去年同期的15.38亿美元销售额增长了5.46％。